Dr. Axel Svedbom, MSc, PhD, is a Researcher at the Karolinska Institutet, Stockholm, Sweden. He completed his PhD in register-based research in psoriasis in 2021. He is widely published in Dermatology, with numerous abstracts and papers published in the JAMA Dermatology, the Journal of the American Academy of Dermatology (JAAD), the Journal of Investigative Dermatology (JID), and the Journal of the European Academy of Dermatology (JEADV). Dr. Svedbom’s research focuses on integrating data from the lab, patients, medical records, and registers to predict the long-term development of psoriasis and understand the mechanisms underlying the associations between psoriasis and other diseases such as cardiovascular disease, depression, and inflammatory bowel disease. To this end, he works with four distinct and unique cohorts. He has received grants from the National Psoriasis Foundation (NPF), the Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA), and the Swedish Psoriasis Foundation.
Focus on Psoriasis: A Report from the 32nd European Academy of Dermatology and Venereology 2023 Congress (EADV).
Access the latest insights from the 32nd European Academy of Dermatology and Venereology 2023 Congress (EADV) in…